Unusual Manifestations of a Rare Clinical Entity: Erdheim-Chester Disease
DOI:
https://doi.org/10.24950/rspmi/CC/224/18/2/2019Keywords:
Diabetes Insipidus, Neurogenic, Erdheim-Chester Disease, Polydipsia, Retroperitoneal Fibrosis, StrokeAbstract
A 69-year-old woman presented with sudden left hemiparesis. Computed tomography (CT) scan excluded acute brain
injuries. Patient was admitted with acute ischemic stroke of
right hemisphere. There was full recovery within 24 hours and
etiologic studies were normal. There was a concomitant history of ingestion of 6 litres of water per day over the previous
2 years. Water deprivation test followed by the administration
of desmopressin confirmed central diabetes insipidus diagnosis. Brain magnetic resonance imaging (MRI) was normal.
Full body CT scan showed arterial wall thickening suggestive
of large and medium vessels vasculitis, retroperitoneal fibrosis, perinephric infiltration, pleural and pericardial thickening and diffuse densification of greater omentum. Angio-MRI
showed occlusive micro-arterial injuries. Laparoscopic biopsy of greater omentum revealed multinucleated giant Touton
CD68+, CD1A- cells. This finding is pathognomonic of Erdheim-Chester Disease, a rare non-Langerhans histiocytosis
Downloads
References
Haroche J, Cohen-Aubart F, Charlotte F, Maksud P, Grenier P, Cluzel P, et al. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm. Expert Rev Clin Immunol. 2015;11:1033-42. doi: 10.1586/1744666X.2015.1060857.
Diamond EL, Dagna L, Hyman DM, Cavalli G, Janku F, Estrada-Veras J, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124:483-92. doi: 10.1182/ blood-2014-03-561381.
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms Blood. 2016;127:2375-90. doi: 10.1182/ blood-2016-01-643569.
Haroche J, Cohen-Aubart F, Rollins BJ, Donadieu J, Charlotte F, Idbaih A, et al. Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol. 2017;18:e113-e125. doi: 10.1016/ S1470-2045(17)30031-1.
Haroche J, Arnaud L, Amoura Z. Erdheim–Chester disease. Curr Opin Rheumatol. 2012;24:53–9.
Arnaud L, Hervier B, Néel A, Hamidou MA, Kahn JE, Wechsler B, et al. CNS involvement and treatment with interferon- are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117:2778-82. doi: 10.1182/blood-2010-06-294108.
Cives M, Simone V, Rizzo FM, Dicuonzo F, Cristallo Lacalamita M, Ingravallo G, et al. Erdheim–Chester disease: A systematic review. Crit Rev Oncol Hematol. 2015;95:1-11. doi: 10.1016/j.critrevonc.2015.02.004.
Tran TA, Pariente D, Lecron JC, Delwail A, Taoufik Y, Meinzer U. Treatment of pediatric Erdheim-Chester disease with interleukin-1- targeting drugs. Arthritis Rheum. 2011;63:4031-32. doi: 10.1002/art.30638.
Killu AM, Liang JJ, Jaffe AS. Erdheim-Chester disease with cardiac involvement successfully treated with anakinra. Int J Cardiol. 2013;167:e115-7. doi: 10.1016/j.ijcard.2013.04.057.
Dagna L, Corti A, Langheim S, Guglielmi B, De Cobelli F, Doglioni C, et al. Tumor necrosis factor a as a master regulator of inflammation in Erdheim- -Chester disease: rationale for the treatment of patients with infliximab. J Clin Oncol. 2012;30:e286-90.
Jendro MC, Zeidler H, Rosenthal H, Haller H, Schwarz A. Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol. 2004;23:52-6.
Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121:1495-500. doi: 10.1182/ blood-2012-07-446286.
Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine. 1996;75:157-69.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
